Literature DB >> 26546606

DNA-PKcs Is Involved in Ig Class Switch Recombination in Human B Cells.

Andrea Björkman1, Likun Du1, Kerstin Felgentreff2, Cornelia Rosner1, Radhika Pankaj Kamdar1, Georgia Kokaraki1, Yoshihisa Matsumoto3, E Graham Davies4, Mirjam van der Burg5, Luigi D Notarangelo6, Lennart Hammarström1, Qiang Pan-Hammarström7.   

Abstract

Nonhomologous end-joining (NHEJ) is one of the major DNA double-strand break repair pathways in mammalian cells and is required for both V(D)J recombination and class switch recombination (CSR), two Ig gene-diversification processes occurring during B cell development. DNA-dependent protein kinase, catalytic subunit (DNA-PKcs) is a component of the classical NHEJ machinery and has a critical function during V(D)J recombination. However, its role in CSR has been controversial. In this study, we examined the pattern of recombination junctions from in vivo-switched B cells from two DNA-PKcs-deficient patients. One of them harbored mutations that did not affect DNA-PKcs kinase activity but caused impaired Artemis activation; the second patient had mutations resulting in diminished DNA-PKcs protein expression and kinase activity. These results were compared with those from DNA-PKcs-deficient mouse B cells. A shift toward the microhomology-based alternative end-joining at the recombination junctions was observed in both human and mouse B cells, suggesting that the classical NHEJ pathway is impaired during CSR when DNA-PKcs is defective. Furthermore, cells from the second patient showed additional or more severe alterations in CSR and/or NHEJ, which may suggest that DNA-PKcs and/or its kinase activity have additional, Artemis-independent functions during these processes.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26546606     DOI: 10.4049/jimmunol.1501633

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  High-throughput sequencing reveals similar molecular signatures for class switch recombination junctions for the γ and α isotypes.

Authors:  Hussein Issaoui; Nour Ghazzaui; Alexis Saintamand; Yves Denizot; François Boyer
Journal:  Cell Mol Immunol       Date:  2018-03-23       Impact factor: 11.530

Review 2.  The recent advances in non-homologous end-joining through the lens of lymphocyte development.

Authors:  Xiaobin S Wang; Brian J Lee; Shan Zha
Journal:  DNA Repair (Amst)       Date:  2020-06-25

3.  Kinase-dependent structural role of DNA-PKcs during immunoglobulin class switch recombination.

Authors:  Jennifer L Crowe; Zhengping Shao; Xiaobin S Wang; Pei-Chi Wei; Wenxia Jiang; Brian J Lee; Verna M Estes; Frederick W Alt; Shan Zha
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-02       Impact factor: 11.205

Review 4.  Current insights into the mechanism of mammalian immunoglobulin class switch recombination.

Authors:  Kefei Yu; Michael R Lieber
Journal:  Crit Rev Biochem Mol Biol       Date:  2019-09-11       Impact factor: 8.250

5.  CDCA7 and HELLS mutations undermine nonhomologous end joining in centromeric instability syndrome.

Authors:  Motoko Unoki; Hironori Funabiki; Guillaume Velasco; Claire Francastel; Hiroyuki Sasaki
Journal:  J Clin Invest       Date:  2018-11-19       Impact factor: 14.808

6.  The H2B deubiquitinase Usp22 promotes antibody class switch recombination by facilitating non-homologous end joining.

Authors:  Conglei Li; Thergiory Irrazabal; Clare C So; Maribel Berru; Likun Du; Evelyn Lam; Alexanda K Ling; Jennifer L Gommerman; Qiang Pan-Hammarström; Alberto Martin
Journal:  Nat Commun       Date:  2018-03-08       Impact factor: 14.919

Review 7.  ATM, ATR and DNA-PKcs kinases-the lessons from the mouse models: inhibition ≠ deletion.

Authors:  Demis Menolfi; Shan Zha
Journal:  Cell Biosci       Date:  2020-01-29       Impact factor: 7.133

8.  DNA-PKcs phosphorylation at the T2609 cluster alters the repair pathway choice during immunoglobulin class switch recombination.

Authors:  Jennifer L Crowe; Xiaobin S Wang; Zhengping Shao; Brian J Lee; Verna M Estes; Shan Zha
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-31       Impact factor: 11.205

9.  DNA-PKcs Inhibition Extends Allogeneic Skin Graft Survival.

Authors:  David K Harrison; Zachary J Waldrip; Lyle Burdine; Sara C Shalin; Marie Schluterman Burdine
Journal:  Transplantation       Date:  2021-03-01       Impact factor: 5.385

10.  Rap1 regulates hematopoietic stem cell survival and affects oncogenesis and response to chemotherapy.

Authors:  Ekta Khattar; Kyaw Ze Ya Maung; Chen Li Chew; Arkasubhra Ghosh; Michelle Meng Huang Mok; Pei Lee; Jun Zhang; Wei Hong Jeff Chor; Gökhan Cildir; Chelsia Qiuxia Wang; Nur Khairiah Mohd-Ismail; Desmond Wai Loon Chin; Soo Chin Lee; Henry Yang; Yong-Jae Shin; Do-Hyun Nam; Liming Chen; Alan Prem Kumar; Lih Wen Deng; Masahito Ikawa; Jayantha Gunaratne; Motomi Osato; Vinay Tergaonkar
Journal:  Nat Commun       Date:  2019-12-13       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.